Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! Please be sure to document all clinical activities daily.
Thayer B, Edwards JD, Belk MG, Durham SH. Evaluation of a Pharmacist-Led MRSA Nasal PCR Testing Protocol. DOI →
Steuber T, Gipson H, Boyett B, Belk M, Thayer B, Edwards J. Multi-dose oritavancin vs dalbavancin for complicated infections: a propensity score-matched analysis. DOI →
Dosing and administration strategies of tocilizumab in patients with COVID-19: a retrospective cohort analysis. DOI →
Effect of microbiology comment nudging on antibiotic use in asymptomatic bacteriuria: a before-and-after quasi-experimental study. DOI →
Efficacy and safety of commercialized fecal microbiota transplant for recurrent Clostridioides difficile infection. DOI →
Medications not yet evaluated by P&T are considered non-formulary. Always confirm two identifiers — name and date of birth. Document all clinical activities daily.